ABBN.SW: $86.02 ▼ -0.08 (-0.09%)ASML.AS: $1,571.80 ▲ 11.00 (0.70%)ENR.DE: $160.78 ▼ -1.72 (-1.06%)GLEN.L: $536.40 ▲ 1.10 (0.21%)IFX.DE: $81.13 ▲ 0.57 (0.71%)NOKIA.HE: $12.11 ▲ 0.11 (0.92%)RIO.L: $7,303.00 ▲ 39.00 (0.54%)AMD: $519.85 ▼ -31.78 (-5.76%)INTC: $132.28 ▼ -8.66 (-6.14%)MU: $1,051.77 ▼ -159.61 (-13.18%)WDC: $670.75 ▼ -61.87 (-8.45%)AAPL: $294.30 ▼ -2.71 (-0.91%)AMZN: $234.11 ▲ 1.32 (0.57%)NVDA: $200.04 ▼ -8.61 (-4.13%)AMAT: $585.88 ▼ -54.30 (-8.48%)CIEN: $459.85 ▼ -0.48 (-0.10%)STX: $1,038.59 ▼ -55.45 (-5.07%)

Company Details

Janus Henderson Global Life Sciences Fund Class A

JFNAX - NASDAQ

Identifiants & Marche

Ticker JFNAX
ISIN US4710234810
CIK 0000277751
Bourse NASDAQ
Devise USD

Classification

Entreprise

Pays US
Siege N/A
Fondee N/A
Site Web N/A

Description

The investment seeks long-term growth of capital. The fund pursues its investment objective by investing, under normal circumstances, at least 80% of its net assets (plus any borrowings for investment purposes) in securities of companies that the portfolio managers believe have a life science orientation. In the fund's pursuit of companies with a life science orientation, the fund has a fundamental policy to normally invest at least 25% of its total assets in securities of companies that are categorized in the "life sciences" sector.